Blair William & Co. IL Decreases Holdings in CVS Health Co. (NYSE:CVS)

Blair William & Co. IL lowered its position in CVS Health Co. (NYSE:CVS) by 10.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 412,807 shares of the pharmacy operator’s stock after selling 48,714 shares during the period. Blair William & Co. IL’s holdings in CVS Health were worth $32,926,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of CVS. Atticus Wealth Management LLC lifted its stake in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the period. USA Financial Formulas raised its position in CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. purchased a new position in shares of CVS Health during the 4th quarter worth $32,000. Creekmur Asset Management LLC purchased a new stake in shares of CVS Health in the 4th quarter worth $34,000. Finally, Steph & Co. raised its holdings in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.6 %

Shares of NYSE:CVS traded down $0.34 during trading on Friday, reaching $59.57. The company’s stock had a trading volume of 6,582,282 shares, compared to its average volume of 11,677,024. The stock has a market capitalization of $74.78 billion, a PE ratio of 10.47, a price-to-earnings-growth ratio of 0.59 and a beta of 0.52. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The firm’s 50 day simple moving average is $58.56 and its two-hundred day simple moving average is $68.37.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $2.20 earnings per share. On average, research analysts predict that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd will be issued a $0.665 dividend. The ex-dividend date is Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.47%. CVS Health’s payout ratio is 46.75%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. SVB Leerink restated a “market perform” rating and set a $60.00 target price (down previously from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. The Goldman Sachs Group reduced their price objective on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Barclays lowered their target price on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 2nd. Finally, Truist Financial reiterated a “buy” rating and issued a $66.00 price target (down previously from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Eleven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.05.

Insider Buying and Selling

In other news, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.24% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.